Clinical trial
A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid…
NCT00424294 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00424294 |
|---|---|
| Title | A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of CP-195543 And Celecoxib Dual Therapy In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis In Subjects Who Are Inadequately Controlled On Methotrexate |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | CP-195, 543, celecoxib, Methotrexate |
| Enrollment | 70 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Jan 19, 2007 |
| Last update posted | Sep 25, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: